Ghrelin Stimulates Endothelial Cells Angiogenesis through Extracellular Regulated Protein Kinases (ERK) Signaling Pathway
Tirzepatide, a dual GIP/GLP-1 receptor agonist, has demonstrated greater efficacy in clinical trials, including the head-to-head SURMOUNT-5 trial comparing it to semaglutide 2.4 mg, potentially producing more substantial weight loss than traditional GLP-1 agonists alone
In Australia, the burden of Healthcare-associated infections are estimated around 165,000 annually comprising bacterial associated urinary tract infections, blood stream infection, pneumonia, surgical site infections, respiratory Infections etc
Kim KS, Seu YB, Baek SH, Kim MJ, Kim KJ, Kim JH, Kim JR
Drucker of the University of Toronto
Ethn Dis 16(3):682692 Goyal RK (2021) Gastric emptying abnormalities in diabetes mellitus